Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 234 Breast Neoplasms 132 Neoplasms 97 Prostatic Neoplasms 34 Fatigue 34 Obesity 24 Lung Neoplasms 23 Colorectal Neoplasms 22 Polycystic Ovary Syndrome 17 Ovarian Neoplasms 13 Colonic Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Leukemia 9 Insulin Resistance 8 Cardiotoxicity 8 Brain Neoplasms 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 7 Overweight 6 Esophageal Neoplasms 6 Cognitive Dysfunction 6

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Interleukin-2 9 Melphalan 8 CTLA-4 Antigen 8 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 tebentafusp 6 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Blood Specimen Collection 4 Biopsy 4 trametinib 3 sotrastaurin 3 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Exercise × Clear all

NCT06970236 2025-05-28

IHOPE

University of Valencia

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡